Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study

Lenalidomide-based regimens are effective treatment options for patients with relapsed/refractory multiple myeloma (RRMM). However, they are associated with an increased risk of infectious complications. This study examines the clinical factors influencing the occurrence of infection in MM patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikulski, Damian, Robak, Paweł, Ryżewska, Wiktoria, Stańczak, Kamila, Kościelny, Kacper, Góra-Tybor, Joanna, Robak, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572774/
https://www.ncbi.nlm.nih.gov/pubmed/36233774
http://dx.doi.org/10.3390/jcm11195908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572774/
https://www.ncbi.nlm.nih.gov/pubmed/36233774
http://dx.doi.org/10.3390/jcm11195908

Ejemplares similares